Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Plasma Cell Myeloma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Contact: Study coordinator (Mansi R. Shah, MD) · shahmr@cinj.rutgers.edu · 732-235-4439
Contact: Principal Investigator (Mansi Shah)
RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Brunswick, New Jersey, United States

Study leads

Mansi R. Shah, MD
Principal Investigator
Rutgers Cancer Institute of New Jersey

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

Plasma Cell Myeloma Refractory

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Los Angeles, United States

Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study

B-Cell Non-Hodgkin Lymphoma · Multiple Myeloma

Abroad (travel likely)RecruitingPHASE2

Duarte, United States